Insulet | PODD - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 11.16B 300M 2026-03
Align Technology USD 1.04B 10M 2026-03
AtriCure USD 141.2M 700K 2026-03
Avanos Medical USD 182.2M 1.3M 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Cardinal Health USD 60.9B 4.73B 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
ICU Medical USD 525.77M 14.93M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Masimo USD 403.6M 8.9M 2026-03
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 381.9M 12M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Solventum Corp USD 2.01B 20M 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
West Pharmaceutical Services USD 844.9M 39.9M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03